Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $453,163 | 179 | 100.0% |
| Food and Beverage | $33.16 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $286,363 | 113 | $0 (2024) |
| Shire North American Group Inc | $166,800 | 66 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $21.73 | 2 | $0 (2018) |
| Allergan Inc. | $11.43 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,300 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($66,300) |
| 2023 | $42,863 | 17 | Takeda Pharmaceuticals U.S.A., Inc. ($42,863) |
| 2022 | $61,900 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($61,900) |
| 2021 | $55,800 | 22 | Takeda Pharmaceuticals U.S.A., Inc. ($55,800) |
| 2020 | $59,500 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($59,500) |
| 2019 | $58,400 | 24 | Shire North American Group Inc ($58,400) |
| 2018 | $52,433 | 21 | Shire North American Group Inc ($52,400) |
| 2017 | $56,000 | 24 | Shire North American Group Inc ($56,000) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 05/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 249 | 253 | $228,711 | $28,618 |
| 2022 | 6 | 268 | 270 | $222,593 | $30,194 |
| 2021 | 4 | 297 | 301 | $270,487 | $35,603 |
| 2020 | 4 | 298 | 304 | $271,047 | $35,946 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 145 | 147 | $159,054 | $18,824 | 11.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 47 | 47 | $35,015 | $4,246 | 12.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 19 | $26,391 | $2,960 | 11.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 29 | $5,336 | $1,708 | 32.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $2,915 | $880.94 | 30.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 137 | 139 | $150,398 | $18,821 | 12.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 42 | 42 | $30,835 | $3,744 | 12.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 33 | $10,527 | $3,305 | 31.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 11 | $14,549 | $1,801 | 12.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 33 | 33 | $13,464 | $1,636 | 12.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,820 | $886.89 | 31.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 126 | 126 | $134,241 | $18,734 | 14.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 107 | 111 | $81,735 | $9,629 | 11.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 30 | 30 | $40,889 | $5,647 | 13.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 34 | 34 | $13,622 | $1,593 | 11.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 152 | 158 | $162,376 | $21,977 | 13.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 105 | 105 | $72,541 | $8,943 | 12.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 23 | 23 | $29,704 | $4,219 | 14.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 18 | 18 | $6,426 | $805.87 | 12.5% |
About Dr. Anthony Carter, DO
Dr. Anthony Carter, DO is a Emergency Medicine healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386610947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Carter, DO has received a total of $453,196 in payments from pharmaceutical and medical device companies, with $66,300 received in 2024. These payments were reported across 182 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($453,163).
As a Medicare-enrolled provider, Carter has provided services to 1,112 Medicare beneficiaries, totaling 1,128 services with total Medicare billing of $130,360. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Cedar Rapids, IA
- Active Since 02/24/2006
- Last Updated 02/26/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1386610947
Products in Payments
- XARELTO (Drug) $21.73
- DALVANCE (Drug) $11.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Cedar Rapids
Yasir Elhawi, Md, MD
Emergency Medicine — Payments: $354.01
Dr. Devin Toll, D.o,, D.O,
Emergency Medicine — Payments: $340.36
Dr. Eric Hovda, Do, DO
Emergency Medicine — Payments: $146.35
Craig Hovda, Md, MD
Emergency Medicine — Payments: $90.22
Donald Linder, Do, DO
Emergency Medicine — Payments: $68.64
Dr. Joshua Pruitt, M.d, M.D
Emergency Medicine — Payments: $63.55